---
category: listing
circular_id: f946cc6c81c9daf1
date: '2025-12-31'
description: 16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on
  BSE with effect from January 1, 2026, issued on preferential basis pursuant to warrant
  conversion.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={D243424B-B1C3-4092-807E-40C0A57AE015}&noticeno=20251231-15&dt=12/31/2025&icount=15&totcount=59&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of preferential shares after warrant conversion with
  limited market impact due to lock-in requirements
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251231-15&attachedId=
processing:
  attempts: 1
  content_hash: 12bfb388e2b15d62
  processed_at: '2025-12-31T18:55:29.494181'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-31T09:10:42+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={D243424B-B1C3-4092-807E-40C0A57AE015}&noticeno=20251231-15&dt=12/31/2025&icount=15&totcount=59&flag=0
severity: low
source: bse
stocks:
- NOVELIX
tags:
- listing
- equity-shares
- preferential-allotment
- warrant-conversion
- lock-in
title: Listing of New Securities of NOVELIX PHARMACEUTICALS LIMITED
---

## Summary

BSE has listed 16,61,000 equity shares of NOVELIX PHARMACEUTICALS LIMITED (Scrip Code: 536565) with effect from January 1, 2026. These shares were issued at Rs. 20/- (Rs. 10/- face value + Rs. 10/- premium) to Promoter and Non-Promoter on preferential basis pursuant to conversion of warrants. The shares rank pari-passu with existing equity shares.

## Key Points

- Total shares listed: 16,61,000 equity shares of Rs. 10/- each
- Issue price: Rs. 20/- per share (including premium of Rs. 10/-)
- Distinctive Numbers: 14480001 to 16141000
- Date of Allotment: October 23, 2025
- Effective trading date: January 1, 2026
- ISIN: INE314I01036
- Shares rank pari-passu with existing equity shares

## Regulatory Changes

No regulatory changes introduced by this circular.

## Compliance Requirements

Trading members must note the new securities available for trading from January 1, 2026, subject to lock-in restrictions.

## Important Dates

- **Date of Allotment**: October 23, 2025
- **Trading Commencement**: January 1, 2026
- **Lock-in Expiry (5,36,000 shares)**: July 31, 2026 (Dist. Nos. 15605001 to 16141000)
- **Lock-in Expiry (11,25,000 shares)**: July 31, 2027 (Dist. Nos. 14480001 to 15605000)

## Impact Assessment

Limited market impact expected as:
- This is a routine listing following warrant conversion
- Significant lock-in periods apply: 11,25,000 shares locked until July 2027 and 5,36,000 shares locked until July 2026
- Shares issued on preferential basis to Promoter and Non-Promoter groups
- Total dilution represents additional capital raised through warrant conversion mechanism